focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Replacement of Shire plc

19 Dec 2018 14:40

RNS Number : 0151L
Morgan Stanley & Co. Int'l plc
19 December 2018
 

AMENDMENT Section (2a & 2b)

 

 FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date dealing undertaken:

17 DECEMBER 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Takeda Pharmaceutical Company Limited

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

 Class of

relevant

security

 Purchases/

sales

 Total number

of securities

 Highest price

per unit paid/received

 Lowest price

per unit paid/received

 5p ordinary

 PURCHASES

 2,466,340

 46.3900 GBP

 45.0900 GBP

 

 5p ordinary

 SALES

 1,866,149

 46.4300 GBP

 45.1000 GBP

 

 5p ordinary

 PURCHASES

 240,543

 57.4384 USD

 57.0155 USD

 

 5p ordinary

 SALES

 361,892

 58.7118 USD

 56.8514 USD

 

 

 

(b) Cash-settled derivative transactions

 

 Class of

relevant

security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per

unit

 5p ordinary

 CFD

 LONG

 12,261

 45.3250 GBP

 

 5p ordinary

 CFD

 LONG

 12,260

 45.3250 GBP

 

 5p ordinary

 CFD

 LONG

 4,308

 45.3250 GBP

 

 5p ordinary

 CFD

 LONG

 23,993

 45.4076 GBP

 

 5p ordinary

 CFD

 LONG

 7,912

 45.4076 GBP

 

 5p ordinary

 CFD

 LONG

 2,000

 45.4139 GBP

 

 5p ordinary

 CFD

 LONG

 49,480

 45.5459 GBP

 

 5p ordinary

 CFD

 LONG

 178

 45.5550 GBP

 

 5p ordinary

 CFD

 LONG

 79

 45.7988 GBP

 

 5p ordinary

 CFD

 LONG

 14,322

 45.8100 GBP

 

 5p ordinary

 CFD

 LONG

 5,678

 45.8100 GBP

 

 5p ordinary

 CFD

 LONG

 157

 46.1349 GBP

 

 5p ordinary

 CFD

 LONG

 388

 46.2462 GBP

 

 5p ordinary

 CFD

 LONG

 25

 46.2920 GBP

 

 5p ordinary

 CFD

 LONG

 7

 46.2920 GBP

 

 5p ordinary

 CFD

 LONG

 109

 46.2920 GBP

 

 5p ordinary

 CFD

 LONG

 24

 46.2920 GBP

 

 5p ordinary

 CFD

 LONG

 116

 46.2920 GBP

 

 5p ordinary

 CFD

 LONG

 130

 46.2920 GBP

 

 5p ordinary

 CFD

 LONG

 30

 46.2920 GBP

 

 5p ordinary

 CFD

 LONG

 156

 46.3807 GBP

 

 5p ordinary

 CFD

 SHORT

 53,550

 45.2585 GBP

 

 5p ordinary

 CFD

 SHORT

 20,211

 45.2588 GBP

 

 5p ordinary

 CFD

 SHORT

 1,555

 45.2738 GBP

 

 5p ordinary

 CFD

 SHORT

 10

 45.2850 GBP

 

 5p ordinary

 CFD

 SHORT

 218

 45.3250 GBP

 

 5p ordinary

 CFD

 SHORT

 4,308

 45.3250 GBP

 

 5p ordinary

 CFD

 SHORT

 1,719

 45.3659 GBP

 

 5p ordinary

 CFD

 SHORT

 9,754

 45.3659 GBP

 

 5p ordinary

 CFD

 SHORT

 12,200

 45.3659 GBP

 

 5p ordinary

 CFD

 SHORT

 6,012

 45.3659 GBP

 

 5p ordinary

 CFD

 SHORT

 160

 45.3913 GBP

 

 5p ordinary

 CFD

 SHORT

 413

 45.4063 GBP

 

 5p ordinary

 CFD

 SHORT

 4,789

 45.4063 GBP

 

 5p ordinary

 CFD

 SHORT

 4,844

 45.4150 GBP

 

 5p ordinary

 CFD

 SHORT

 159

 45.5002 GBP

 

 5p ordinary

 CFD

 SHORT

 403

 45.5236 GBP

 

 5p ordinary

 CFD

 SHORT

 2,905

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 236

 45.5420 GBP

 

 5p ordinary

 CFD

 SHORT

 68,500

 45.6636 GBP

 

 5p ordinary

 CFD

 SHORT

 66

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 51,003

 45.6763 GBP

 

 5p ordinary

 CFD

 SHORT

 707

 45.7532 GBP

 

 5p ordinary

 CFD

 SHORT

 14,322

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 5,678

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 3,819

 45.7950 GBP

 

 5p ordinary

 CFD

 LONG

 248,631

 45.4089 GBP

 

 5p ordinary

 CFD

 LONG

 150,000

 58.7118 USD

 

 5p ordinary

 CFD

 SHORT

 16,182

 45.2115 GBP

 

 5p ordinary

 CFD

 SHORT

 315

 45.2115 GBP

 

 5p ordinary

 CFD

 SHORT

 8,820

 45.2672 GBP

 

 5p ordinary

 CFD

 SHORT

 25,000

 45.4133 GBP

 

 5p ordinary

 CFD

 SHORT

 3,900

 45.4504 GBP

 

 5p ordinary

 CFD

 SHORT

 1,800

 45.4504 GBP

 

 5p ordinary

 CFD

 SHORT

 1,411

 45.4504 GBP

 

 5p ordinary

 CFD

 SHORT

 8,300

 45.4504 GBP

 

 5p ordinary

 CFD

 SHORT

 2,682

 46.2128 GBP

 

 5p ordinary

 CFD

 SHORT

 17,034

 57.1491 USD

 

 5p ordinary

 CFD

 SHORT

 42,966

 57.1491 USD

 

 5p ordinary

 CFD

 SHORT

 50,127

 57.1923 USD

 

 5p ordinary

 CFD

 SHORT

 19,873

 57.1923 USD

 

 5p ordinary

 CFD

 SHORT

 4,200

 57.3099 USD

 

 5p ordinary

 CFD

 SHORT

 706

 57.3099 USD

 

 5p ordinary

 CFD

 SHORT

 900

 57.3099 USD

 

 5p ordinary

 CFD

 SHORT

 2,000

 57.3099 USD

 

 5p ordinary

 CFD

 SHORT

 50,127

 57.3487 USD

 

 5p ordinary

 CFD

 SHORT

 19,873

 57.3487 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of

relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(ii) Exercise

 

 Class of

relevant

security

 Product description

e.g. call option

 Exercising/

exercised

against

 Number of securities

 Exercise price

per unit

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing

e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A  

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 (b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 Date of disclosure:

 19 DECEMBER 2018

 

 Contact name:

 Craig Horsley

 

 Telephone number:

 +44(141) 245 7736

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERLLFVSFRLALIT
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.